Publication of preclinical findings for ATXA Therapeutics' NTP42
ATXA Therapeutics have published a new paper detailing results of its lead drug candidate NTP42 in a preclinical model of pulmonary...
Publication of preclinical findings for ATXA Therapeutics' NTP42
100 Hot Start Ups.
ATXA & PAH- Hope attend ERS Congress 2019 in Madrid
ATXA attends the ESC Congress 2019 in Paris
ESC Congress Paris 2019
Experimental and Molecular Pathology
New paper on thromboxane receptors in prostate inflammation published in Experimental and Molecular
EIC Welcomes Entrepreneurs
Funding Opportunities for Breakthrough Innovation
Irish life sciences start-ups to watch